{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-018824","form_type":"8-K","ticker":null,"cik":"0001538217","company_name":"SRAX, Inc.","filed_at":"2024-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.893436+00:00","generated_at":"2026-06-02T02:17:23.975659+00:00","sec_items":["1.01","8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"SRAX signs definitive merger agreement with DNA Holdings; DNA shareholders to get ~75.5% of SRAX common stock","bullets":["SRAX will issue 1,000 shares of Series C Preferred Stock convertible into ~75.5% of SRAX common stock upon closing.","DNA currently owns ~35% of SRAX; the combined company will be renamed DNA Holdings Venture Inc.","Closing conditions include DNA advancing at least $500,000 to SRAX and SRAX becoming current on SEC filings.","Christopher Miglino will remain CEO of the combined entity; the boards of both companies unanimously approved the deal."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-018824","json":"https://secwatch.observer/filing/0001493152-24-018824.json","markdown":"https://secwatch.observer/filing/0001493152-24-018824.md","text":"https://secwatch.observer/filing/0001493152-24-018824.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1538217/000149315224018824/0001493152-24-018824-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1538217/000149315224018824/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T02:17:23.975659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"523b1e3f31909055da52f6d2beb6ad9874c4096a","claim":"SRAX, Inc. entered into Agreement and Plan of Merger with DNA Holdings Venture, Inc. (effective 2024-05-07).","evidence_excerpt":"On May 7, 2024, SRAX, Inc., a Delaware corporation (“SRAX”), entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with DNA Holdings Venture, Inc., a Puerto Rico corporation (“DNA”), and DNA Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of SRAX (“Merger Sub”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1538217/000149315224018824/0001493152-24-018824-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"DNA Holdings Venture, Inc."},{"label":"Effective","value":"2024-05-07"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}